Gait Analysis and Orthotics for Diabetic Foot Ulcer Prevention
This study is looking at whether using Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and custom orthotics (special shoe inserts) can help reduce the chance of new diabetic foot ulcers or amputations. You may be able to join if you are between 18 and 90 years old and have had a diabetic foot ulcer that has now healed. The study will measure how many times new ulcers appear over one year to see if the intervention is successful. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 69 participants. It aims to evaluate a physical therapy evaluation combined with Noraxon-based gait assessment.
- What's involved
- You would undergo a physical therapy evaluation and gait assessments using special software and instrumented insoles. Custom orthotics or ankle-foot prostheses would then be made and evaluated.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one year to track the number of re-ulceration occurrences.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Ronald Sherman, DPM, MBA · PRINCIPAL_INVESTIGATOR · Johns Hopkins University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of re-ulceration occurrencesOne year
Number of re-ulceration occurrences will be assessed to determine the rate of re-ulceration in patients.